JP/ZH: Currently, only the Luminex LTG section and the Service & Support pages regarding Luminex LTG are available in Japanese/Chinese.
02/10/26 - 14:22
Margherita Sacerdoti appointed Investor Relations & ESG Senior Director at Diasorin (151.77 KB)
04/05/26 - 17:45
Diasorin Strengthens its Leadership of Immuno Division with the Appointment of Gabriele Allegri as President (158.42 KB)
29/04/26 - 15:52
Shareholders' Meeting 2026 (166.06 KB)
07/04/26 - 10:05
Communication on total amount of voting rights (7 April 2026) (225.44 KB)
19/03/26 - 9:47
Diasorin signs strategic distribution agreement with McKesson Medical Surgical to expand access for the LIAISON NES molecular point‑of‑care platform (234.16 KB)
27/01/26 - 16:05
The Shareholders' meeting authorized the purchase of treasury shares, approved the amendment of art. 5 of the articles of association and authorized the cancellation of treasury shares. The Board approved the launch of the buyback plan. (120.91 KB)
23/01/26 - 17:49
Succession in the role of Group Chief Financial Officer of Diasorin. Alberto Donati appointed new Group Chief Financial Officer. (108.99 KB)
05/09/24 - 11:17
DiaSorin S.p.A. - Update 2024 Annual Calendar of Corporate Events (99.93 KB)
04/09/24 - 11:36
Diasorin S.p.A. - Shareholders' Meeting September 4, 2024 (136.09 KB)
24/04/24 - 15:38
Shareholders' Meeting 2024 (159.72 KB)
04/04/24 - 9:34
DiaSorin S.p.A.- Update 2024 Annual Calendar of Corporate Events (103.76 KB)
18/01/24 - 12:30